Adjuvant radiotherapy for completely resected stage 2 thymoma

Cancer

Volumn 117, Issue 15, 2011, Pages 3502-3508

  Berman, Abigail T ^a   Litzky, Leslie ^b   Livolsi, Virginia ^b   Singhal, Sunil ^b   Kucharczuk, John C ^b   Cooper, Joel D ^b   Friedberg, Joseph R ^b   Evans, Tracey L ^b   Stevenson, James P ^b   Metz, James M ^a   Hahn, Stephen M ^a   Rengan, Ramesh ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adjuvant therapy; radiation oncology; stage II; thymic neoplasm (thymoma)

Indexed keywords

ADJUVANT RADIOTHERAPY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION PNEUMONIA; RECURRENCE RISK; THYMECTOMY; THYMOMA; TUMOR RECURRENCE;

COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; THYMOMA; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 79960700154     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25851     Document Type: Article

References (29)

1. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981; 48: 2485-2492. (Pubitemid 12228012)
2. Pescarmona E, Rendina EA, Venuta F, et al. Analysis of prognostic factors and clinicopathological staging of thymoma. Ann Thorac Surg. 1990; 50: 534-538. (Pubitemid 20360810)
3. Quintanilla-Martinez L, Wilkins EW Jr, Choi N, et al. Thymoma. Histologic subclassification is an independent prognostic factor. Cancer. 1994; 74: 606-617. (Pubitemid 24217624)
4. Okumura M, Ohta M, Miyoshi S, et al. Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients. Jpn J Thorac Cardiovasc Surg. 2002; 50: 189-194. (Pubitemid 38166175)
5. Park MS, Chung KY, Kim KD, et al. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg. 2004; 78: 992-997; discussion 997-998.
6. Lardinois D, Rechsteiner R, Lang RH, et al. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg. 2000; 69: 1550-1555. (Pubitemid 30434891)
7. Okumura M, Miyoshi S, Takeuchi Y, et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg. 1999; 117: 605-613. (Pubitemid 29117544)
8. Kondo K, Monden Y,. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg. 2003; 76: 878-884; discussion 884-875. (Pubitemid 37100765)
9. Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg. 2003; 126: 1134-1140. (Pubitemid 37305702)
10. Okumura M, Ohta M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer. 2002; 94: 624-632. (Pubitemid 34132289)
11. Bergh NP, Gatzinsky P, Larsson S, et al. Tumors of the thymus and thymic region: I. Clinicopathological studies on thymomas. Ann Thorac Surg. 1978; 25: 91-98. (Pubitemid 8298819)
12. Gamondes JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: factors influencing survival. Eur J Cardiothorac Surg. 1991; 5: 124-131.
13. Maggi G, Casadio C, Cavallo A, et al. Thymoma: results of 241 operated cases. Ann Thorac Surg. 1991; 51: 152-156.
14. Giaccone G, Ardizzoni A, Kirkpatrick A, et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 1996; 14: 814-820.
15. Loehrer PJ Sr, Kim K, Aisner SC, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol. 1994; 12: 1164-1168. (Pubitemid 24173929)
16. Pollack A, Komaki R, Cox JD, et al. Thymoma: treatment and prognosis. Int J Radiat Oncol Biol Phys. 1992; 23: 1037-1043.
17. Curran WJ Jr, Kornstein MJ, Brooks JJ, et al. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 1988; 6: 1722-1727. (Pubitemid 19089051)
18. Gripp S, Hilgers K, Wurm R, et al. Thymoma: prognostic factors and treatment outcomes. Cancer. 1998; 83: 1495-1503. (Pubitemid 28465467)
19. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int. 1994; 44: 359-367. (Pubitemid 24153752)
20. Singhal S, Shrager JB, Rosenthal DI, et al. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg. 2003; 76: 1635-1641; discussion 1641-1642.
21. Ogawa K, Uno T, Toita T, et al. Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer. 2002; 94: 1405-1413. (Pubitemid 34212633)
22. Monden Y, Nakahara K, Iioka S, et al. Recurrence of thymoma: clinicopathological features, therapy, and prognosis. Ann Thorac Surg. 1985; 39: 165-169. (Pubitemid 15166962)
23. Kundel Y, Yellin A, Popovtzer A, et al. Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors. Am J Clin Oncol. 2007; 30: 389-394. (Pubitemid 47356683)
24. Forquer J, Rong N, Fakiris AJ, et al. Postoperative radiotherapy after surgical resection of thymoma: differing roles in local and regional disease. Int J Radiat Oncol Biol Phys. 2010; 76: 440-445.
25. Blumberg D, Port JL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995; 60: 908-913; discussion 914.
26. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg. 2005; 130: 1413-1421. (Pubitemid 41543213)
27. Rena O, Papalia E, Oliaro A, et al. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? Eur J Cardiothorac Surg. 2007; 31: 109-113. (Pubitemid 44880769)
28. Ruffini E, Mancuso M, Oliaro A, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg. 1997; 113: 55-63. (Pubitemid 27034342)
29. Chen G, Marx A, Wen-Hu C, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer. 2002; 95: 420-429. (Pubitemid 34787609)